Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism digital illustration

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism Save


ICD-10 code: E71

Chapter: Endocrine, nutritional and metabolic diseases

Disorders of Branched-Chain Amino-Acid Metabolism and Fatty-Acid Metabolism

Branched-chain amino acids (BCAAs) and fatty acids (FAs) are essential macronutrients that play vital roles in human metabolism. However, genetic mutations can disrupt normal BCAA and FA metabolism, leading to a variety of disorders.

Here are some of the most common disorders of BCAA and FA metabolism:

  1. Maple Syrup Urine Disease (MSUD): This disorder is caused by a deficiency in the enzymes that metabolize BCAAs. As a result, BCAAs and their byproducts accumulate in the blood and urine, causing a sweet, maple syrup-like odor. If left untreated, MSUD can cause severe neurological damage, coma, and even death.
  2. Propionic Acidemia (PA): PA is caused by a deficiency in the enzymes that metabolize certain FAs. As a result, toxic byproducts accumulate in the blood and tissues, leading to metabolic acidosis, seizures, and other neurological symptoms.
  3. Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): MCADD is caused by a deficiency in an enzyme that helps metabolize medium-chain FAs. Without this enzyme, the body cannot produce enough energy, leading to hypoglycemia, seizures, and other symptoms.

Diagnosis of BCAA and FA disorders typically involves blood tests, genetic tests, and urine analysis. Treatment typically involves dietary changes, such as avoiding certain foods and supplementing with specific nutrients. In some cases, medications or other medical interventions may be necessary.

If you or a loved one is experiencing symptoms of a BCAA or FA disorder, it’s important to seek medical attention right away. With proper diagnosis and treatment, many people with these disorders can live long, healthy lives.

Diagnosis Codes for Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism | E71